A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869) (Abbott Laboratories M11-306).
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2011
At a glance
- Drugs Ketoconazole; Linifanib
- Indications Cancer
- Focus Pharmacokinetics
- 17 Mar 2011 Planned End Date changed from 1 Oct 2012 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 17 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 May 2010 Actual initiation date (Apr 2010), planned patient no , trial investigator [McKee MD] added as reported by ClinicalTrials.gov.